secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001599298-24-000025
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics presents at Oppenheimer conference; no material new information in filing
--------------------------------------------------------------------------------

- Presented at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024.
- CEO Dr. Maky Zanganeh and Chairman Bob Duggan listed as presenters.
- No financial data, clinical updates, or material business developments disclosed in the available exhibit.
- Presentation slides furnished under Regulation FD but not filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000025/0001599298-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000025/smmt-20240214.htm
  HTML page:      https://secwatch.observer/filing/0001599298-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer